The Oracle Speaks

Established February 2009

https://theoptionsoracle.com/

5 July 2015

This is a sad day.

Our run of no losses since 2011 is broken. There is no defense against fraud.

When CLDN stopped a trial on one of their drugs, that was no big deal. Not all drugs will work out and we saw it as a positive sign that the company was being responsible and not wasting money on a failed project.

The Options Oracle kept looking and it appeared that the insiders were buying. That was a fraud. Therefore we are joining a class action lawsuit against them.

This stock could go to zero, and as you know, we consider safety first.

Our hope is you only put 5% of your portfolio in this position as we did.

Here is the link to the lawsuit.

https://www.rgrdlaw.com/cases-celladon,join.html

Summary of Trades:

Closed Positions:

CLDN ~ Sell

 

CLDN @ $1.25

Celladon Corporation

Sell

History:

Cost basis $7.50 per share.

Premiums collected: $1.55 per share

Actual Trades:

04/21/2015 Sell To Open CLDN May15 7.5 Put $1.55

Celladon Corporation, a clinical-stage biotechnology company, focuses on developing cardiovascular gene therapy and calcium dysregulation. The company’s lead product candidate includes MYDICAR that uses genetic enzyme replacement therapy to correct the Sarco/endoplasmic reticulum Ca 2+ -ATPase 2a enzyme deficiency in heart failure patients that result in inadequate pumping of the heart. Its MYDICAR product is used to treat patients with systolic heart failure, diastolic heart failure, and advanced heart failure, as well as to treat pulmonary arterial hypertension and arteriovenous fistula maturationfailure. The company is also developing membrane-bound form of Stem Cell Factor for the treatment of cardiac ischemic damage; and compounds for the treatment of diabetes and neurodegenerative diseases. Celladon Corporation was founded in 2000 and is headquartered in San Diego, California.

Celladon Corporation
11988 El Camino Real
Suite 650
San Diego, CA 92130
Phone: 858-366-4288
Fax: 858-964-0974
Website: http://www.celladon.net

Company News

New toll free number:

1-866-466-4617

Free Webinar

Got a question or concern? Want to learn our philosophy, why it pays so well and so consistently?

Register today and watch your emails!

Please use the phone option for audio.

Auto Trading is now active!

Don’t want to be bothered doing the trades? Auto-trading is for you. Your account will automatically copycat our trades.

You are still in control, you set the limits either a dollar amount or a percentage.

Learn how to set up auto-trading here:

https://theoptionsoracle.com/auto-trading/

Like

"Like" us on Facebook

Follow

"Follow" us on Twitter

Quote of the Month:

“Someone’s sitting in the shade today because someone planted a tree a long time ago.” ~ Warren Buffet

Refer a Friend

The greatest compliment you can give us is to share The Options Oracle with your friends.

Military discounts available!

Contact The Options Oracle for details!

Your Name (required)

Your Email (required)

Your Phone Number (required)

Your Message

captcha

CAPTCHA Code

These are actual trades.

The Options Oracle does not tell you what to do, we are showing you what we are doing.

Your subscription fee may be 100% TAX DEDUCTIBLE if used for educational business/investment purposes. Check with your Licensed Professional adviser

Options involve risk and are not suitable for all investors. Prior to trading options, you must be approved for options trading and read the Characteristics and Risks of Standardized Options.

Copies of this document may also be obtained from your broker, from any exchange on which options are traded, by placing an order online, or by contacting the Options Clearing Corporation directly at 1 N. Wacker Dr., Suite 500, Chicago, IL 60606. (1-888-678-4667).

“The Options Oracle” does not manage money for any financial institution. You are purchasing the list of stocks that we use to select options contracts that we feel these options will return the highest, safest profits. We are not a broker or brokers, or a financial adviser. We have developed a successful strategy and are willing to share some of the information that has led to our success. We urge you to paper trade these picks and learn how to develop a strategy that is appropriate for you.

We make no recommendations on investment and we do not provide financial, tax or legal advice. Content and tools are provided for educational and informational purposes only.

Disclaimer

Trading or investment in stocks, futures & options, and commodity are subject to potential market risks. You can use our materials or recommendations for educational purposes, this is not intended as Trading or Investment advice. We are not financial advisers. We cannot provide any advice as to whether or not options or our trading ideas are suitable investments for your particular financial situation. We are in the business of publishing our trade ideas for market analysis only. We highly recommend that our subscribers review their trading allocation with a qualified registered financial adviser/planner.

Legal Disclaimer: we do not exist to render and do not give legal, tax, economic or investment advice and disclaims all liability for the actions or inaction taken or not as a result of communications from or to its members, officers, directors, employees and contractors. Each individual should consult his/her own counsel, accountant and other advisors as to legal, tax, economic, investment and related matters concerning any type of investments.

This email and any files transmitted with it are solely intended for the use of the addressee(s) and may contain information that is confidential and privileged. If you receive this email in error, please advise us by return email immediately. Please also disregard the contents of the email, delete it and destroy any copies immediately.